Save information for later
Sign Up

Learn About Multicentric Castleman Disease (MCD)

View Main Condition: Castleman Disease

What is the definition of Multicentric Castleman Disease (MCD)?
Multicentric Castleman Disease (MCD) is a rare disease that affects the lymph nodes and related tissues. It is a form of Castleman disease that is "systemic" and involves multiple regions of lymph nodes (as opposed to unicentric Castleman disease, which involves a single lymph node or single region of lymph nodes). The signs and symptoms of MCD are often nonspecific, and are mild in some people but serious in others. Symptoms may include enlarged lymph nodes in multiple regions, fever, weight loss, nausea, rash, and/or an enlarged large liver and spleen. The disease is diagnosed based on the symptoms present, laboratory test results, imaging studies, and results of a biopsy of the lymph nodes which shows specific features when studied under the microscope. In some cases, MCD is caused by human herpesvirus-8 (HHV-8) and is referred to as HHV-8-associated MCD. In other cases, the cause is not known and it is referred to as HHV-8 negative MCD, or idiopathic MCD (iMCD).
What are the alternative names for Multicentric Castleman Disease (MCD)?
  • Multicentric Castleman Disease
  • Idiopathic multicentric Castleman's disease
  • MCD
  • Multicentric giant lymph node hyperplasia
  • Multicentric plasma cell variant of Castleman's disease
  • PMCD
  • Plasmablastic multicentric Castleman disease
Who are the top Multicentric Castleman Disease (MCD) Local Doctors?
Elite in Multicentric Castleman Disease (MCD)
Elite in Multicentric Castleman Disease (MCD)
Paris, FR 

Eric Oksenhendler practices in Paris, France. Oksenhendler and is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Lymphoid Hyperplasia, Unicentric Castleman Disease (UCD), and Splenectomy.

Elite in Multicentric Castleman Disease (MCD)
Elite in Multicentric Castleman Disease (MCD)
Université Paris Est, 
Creteil, FR 

Lionel Galicier practices in Creteil, France. Galicier and is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Thrombocytopenia, Splenectomy, and Bone Marrow Aspiration.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Multicentric Castleman Disease (MCD)
Elite in Multicentric Castleman Disease (MCD)
Hemel Hempstead, ENG, GB 

Karan Kanhai practices in Hemel Hempstead, United Kingdom. Kanhai and is rated as an Elite expert by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Castleman Disease, Multicentric Castleman Disease (MCD), Lymphofollicular Hyperplasia, Lymphoid Hyperplasia, and Prostatic Artery Embolization.

What are the latest Multicentric Castleman Disease (MCD) Clinical Trials?
Phase II Study of Pacritinib in Kaposi Sarcoma Herpesvirus (KSHV)-Associated Multicentric Castleman Disease and KSHV-Associated Inflammatory Cytokine Syndrome (KICS)

Background: Kaposi sarcoma herpesvirus (KSHV)-associated inflammatory cytokine syndrome (KICS) and KSHV-multicentric Castleman disease (MCD) occur in people living with HIV. These diseases cause severe inflammation that can be fatal if not treated.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase II Study of Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma and Multicentric Castleman Disease

Background: Primary effusion lymphoma (PEL) is an aggressive form of cancer that affects cells in the immune system and lymph nodes. How PEL develops is not well understood, and this disease does not respond well to standard treatments for other types of lymphomas.

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center

What are some Advocacy Organizations?
castleman-disease

The Castleman Disease Collaborative Network (CDCN) is a global initiative dedicated to accelerating research and treatment for Castleman disease and revolutionizing biomedical research.